Medistim ASA (MEDI.OL)
NOK 161.0
(1.58%)
NOK 161.0
(1.58%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 115.83 Million | 113.49 Million | 128.13 Million | 74.13 Million | 80.38 Million | 55.79 Million |
| Net Income | 103.82 Million | 113.97 Million | 90.9 Million | 69.38 Million | 70.3 Million | 57.05 Million |
| Depreciation & Amortization | 23.65 Million | 23.28 Million | 23.42 Million | 23.14 Million | 18.01 Million | 12.36 Million |
| Deferred income taxes | - | -352 Thousand | -2.42 Million | -1.82 Million | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -19.98 Million | -36.67 Million | 3.97 Million | -21.56 Million | -9.71 Million | -15.5 Million |
| Other non-cash items | 8.34 Million | 12.9 Million | 9.83 Million | 3.17 Million | 1.77 Million | 1.87 Million |
| Investing Cash Flow | -29.72 Million | -21.1 Million | -11.48 Million | -10.63 Million | -13.68 Million | -16.37 Million |
| Investments in PPE | -29.72 Million | -21.1 Million | -11.48 Million | -10.63 Million | -13.68 Million | -16.37 Million |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -13.32 Million | -11.85 Million | -4.08 Million | -3.18 Million | - | - |
| Financing Cash Flow | -84.88 Million | -70.3 Million | -59.05 Million | -58.34 Million | -46.89 Million | -44.73 Million |
| Debt repayment | -8.71 Million | -7.31 Million | -4.5 Million | -3 Million | -3 Million | -4.87 Million |
| Dividends payments | -82.18 Million | -68.39 Million | -54.64 Million | -50.05 Million | -40.92 Million | -36.35 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -2.7 Million | -1.9 Million | 87 Thousand | -5.29 Million | -2.97 Million | -3.5 Million |
| Accounts receivables | 27.35 Million | -33.02 Million | -11.14 Million | 4.7 Million | 8.61 Million | -15 Million |
| Accounts payables | 613 Thousand | 11.26 Million | -324 Thousand | -1.29 Million | 2.89 Million | -1.58 Million |
| Inventory | -31.05 Million | -16.92 Million | 15.25 Million | -22.59 Million | -26.22 Million | -1.12 Million |
| Other working capital | -16.89 Million | 1.99 Million | 196 Thousand | -2.37 Million | 5 Million | -14.37 Million |
| Cash at beginning of period | 152.64 Million | 129.49 Million | 71.89 Million | 66.74 Million | 47.49 Million | 54.41 Million |
| Cash at end of period | 153.87 Million | 152.64 Million | 129.49 Million | 71.89 Million | 66.74 Million | 47.49 Million |
| Capital Expenditure | -29.72 Million | -21.1 Million | -11.48 Million | -10.63 Million | -13.68 Million | -16.37 Million |
| Effect of forex changes on cash | 2.65 Million | 1.06 Million | 764 Thousand | -1000.00 | -549 Thousand | -1.6 Million |
| Net cash flow / Change in cash | 1.23 Million | 23.15 Million | 57.59 Million | 5.14 Million | 19.25 Million | -6.92 Million |
| Free Cash Flow | 86.11 Million | 92.38 Million | 116.65 Million | 63.49 Million | 66.69 Million | 39.42 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 7.2 Million | 34.72 Million | 24.38 Million | 19.1 Million | 103.82 Million | 26.13 Million |
| Depreciation & Amortization | - | 6.42 Million | 6.33 Million | 7.04 Million | 23.65 Million | 5.32 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | - | - | -15.23 Million | -19.98 Million | 21.46 Million |
| Other non-cash items | 23.05 Million | -3.02 Million | 4.07 Million | 30.82 Million | 8.34 Million | -11 Million |
| Investing Cash Flow | -7.89 Million | -3.96 Million | -3.63 Million | -16.9 Million | -29.72 Million | -4.56 Million |
| Investments in PPE | - | - | - | -16.39 Million | -29.72 Million | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -7.89 Million | -3.96 Million | -3.63 Million | -508 Thousand | -13.32 Million | -4.56 Million |
| Financing Cash Flow | -2.09 Million | -84.51 Million | -2.09 Million | 2.61 Million | -84.88 Million | -1.77 Million |
| Debt repayment | - | -84.51 Million | -2.09 Million | -3.39 Million | -8.71 Million | -1.77 Million |
| Dividends payments | - | - | - | - | -82.18 Million | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -2.09 Million | -84.51 Million | - | 2.61 Million | -2.7 Million | - |
| Accounts receivables | - | - | - | 27.35 Million | 27.35 Million | - |
| Accounts payables | - | - | - | 613 Thousand | 613 Thousand | - |
| Inventory | - | - | - | -31.05 Million | -31.05 Million | - |
| Other working capital | - | - | - | -12.14 Million | -16.89 Million | 21.46 Million |
| Cash at beginning of period | 107.05 Million | 170.26 Million | 153.87 Million | 126.42 Million | 152.64 Million | 90.84 Million |
| Cash at end of period | 127.32 Million | 107.05 Million | 170.26 Million | 153.87 Million | 153.87 Million | 126.42 Million |
| Capital Expenditure | - | - | - | -16.39 Million | -29.72 Million | - |
| Effect of forex changes on cash | - | - | - | 2000.00 | 2.65 Million | -1000.00 |
| Net cash flow / Change in cash | 20.26 Million | -63.2 Million | 16.39 Million | 27.45 Million | 1.23 Million | 35.57 Million |
| Free Cash Flow | 30.25 Million | 25.27 Million | 22.11 Million | 25.34 Million | 86.11 Million | 41.91 Million |
WALDW
MYTIL
6516
COF-PJ
BRILL
5191